KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) Return on Equity (2016 - 2025)

Elevance Health (ELV) has disclosed Return on Equity for 16 consecutive years, with 0.06% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 21.0% to 0.06% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.06%, a 21.0% decrease, with the full-year FY2024 number at 0.15%, down 1.0% from a year prior.
  • Return on Equity was 0.06% for Q3 2025 at Elevance Health, up from 0.07% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.17% in Q2 2023 to a low of 1.19% in Q2 2022.
  • A 5-year average of 0.16% and a median of 0.14% in 2024 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: crashed -132bps in 2021, then surged 136bps in 2023.
  • Elevance Health's Return on Equity stood at 1.19% in 2021, then surged by 114bps to 0.16% in 2022, then dropped by -6bps to 0.15% in 2023, then fell by -9bps to 0.14% in 2024, then tumbled by -143bps to 0.06% in 2025.
  • Per Business Quant, the three most recent readings for ELV's Return on Equity are 0.06% (Q3 2025), 0.07% (Q2 2025), and 0.08% (Q1 2025).